The Association for Clinical Oncology (ASCO) is holding its 2021 ASCO Advocacy Summit Week of Action from April 12-16. During the Week of Action, ASCO members can visit ASCO’s easy-to-use ACT Network to quickly and efficiently contact their lawmakers to urge them to take action on cancer policy priorities.
ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.
To sign up for advocacy alerts, log in to ASCO.org with your member or guest account, and visit the subscription center available under your account profile.
Beginning April 1, additional savings may be available for new and current consumers who purchase health insurance on HealthCare.gov following passage of the American Rescue Plan. The Centers for Medicare & Medicaid Services (CMS) also extended access to the Special Enrollment Period (SEP) for the federally funded health insurance marketplace until August 15, to provide additional time for consumers to enroll or make changes to their coverage with the tax credits that become available April 1.
The Association for Clinical Oncology joined the Prevent Cancer Foundation® and more than 300 other organizations from across the country in signing a letter to convey support for the Medicare Multi-Cancer Early Detection Screening Coverage Act. The legislation would allow the Centers for Medicare & Medicaid Services to evaluate and cover multi-cancer early detection tests once they are approved by the Food and Drug Administration.
The American Society of Clinical Oncology (ASCO) and Friends of Cancer Research (Friends) will jointly host a virtual meeting on April 9 to build on efforts to broaden eligibility criteria to make clinical trials more representative.
The Association for Clinical Oncology (ASCO) endorsed the “PREVENT HPV Cancers Act” (H.R. 1550), which was recently introduced by Representative Kathy Castor (FL-14). In a recent letter to the lawmaker, ASCO thanked Rep. Castor for introducing this important measure to increase research on, awareness of, and access to the vaccine which prevents the human papillomavirus (HPV) types that cause most types of cervical cancers as well as some other cancers.
Bipartisan legislation that would require group health insurance plans to implement critical patient protections from step therapy protocols was recently introduced in the United States Senate. The Association for Clinical Oncology (the Association) supports the measure—S. 464, the Safe Step Act—and its aim to ensure patients have timely access to care. The Association is urging Senators to cosponsor the legislation.
President Biden signed an Executive Order (EO) calling for a 100-day review of the United States’ (U.S.) pharmaceutical supply chains in an effort to create more resilient and secure access to essential pharmaceuticals while reducing over reliance on foreign competitors. This EO is driven largely by the personal protective equipment and ventilator shortages healthcare workers experienced during the COVID-19 pandemic as well as other critical supply shortages in non-healthcare sectors.
The American Society of Clinical Oncology’s (ASCO) Road to Recovery Report: Learning from the COVID-19 Experience to Improve Clinical Research and Cancer Care, among other recommendations, calls for the U.S. Department of Health and Human Services (HHS) to establish a special enrollment period on the federal health insurance exchange, abandon plans that limit access to healthcare, and enact policies that enhance access to care for patients with cancer. ASCO applauds the Biden administration for its recent actions supporting policies that aim to promote and protect access to high-quality, equitable cancer care, as outlined in the “Road to Recovery” report.
In the midst of growing concerns that patients with cancer have limited access to the COVID-19 vaccines, the Association for Clinical Oncology (ASCO) and American Cancer Society Cancer Action Network (ACS CAN), advocacy affiliate of the American Cancer Society, today issued a joint letter to every state governor in the United States urging them to prioritize patients with cancer in the distribution of COVID-19 vaccines in accordance with U.S. Centers for Disease Control and Prevention (CDC) guidelines.
ASCO has developed a free educational series to help the oncology community learn more about the role of social determinants of health in cancer care and cancer outcomes.
President Biden signed an executive order (EO) that will reopen HealthCare.gov—the federal health insurance exchange—for a special, three-month enrollment period starting on February 15, 2021. The Association for Clinical Oncology (the Association) applauds this decision, which was a recommendation in American Society of Clinical Oncology’s (the Society) Road to Recovery Report: Learning from the COVID-19 Experience to Improve Clinical Research and Cancer Care. Reopening the federal health insurance exchange will help provide coverage to the millions of Americans who have lost their health insurance amid the COVID-19 pandemic.
A new article published in JCO Oncology Practice puts forth a framework to guide researchers, healthcare leaders, advocates, community- and patient-focused service organizations, and policy leaders in their work to address and promote health equity in cancer care access and treatment outcomes.
The American Society of Clinical Oncology issued a new position statement strongly opposing the use of copay accumulator programs and copay maximizer programs for individuals with cancer. The statement also makes recommendations to protect patients from the potential harms of such programs.
Clinician well-being is a major priority for physicians and practices, and it contributes to quality patient care. A recent survey of ASCO’s membership that found that 45% of medical oncologists reported experiencing emotional exhaustion and/or depersonalization symptoms related to burnout. On Tuesday, January 26, 2021 from 3:30 – 5:00 p.m. ET, the American Society of Clinical Oncology (ASCO) will host an interactive town hall-style webinar to share ASCO’s plans and resources to address this ongoing issue, and to hear members’ perspectives.
The Association for Clinical Oncology responded to two requests for information from the Department of Health and Human Services. One Request for Information sought stakeholder feedback and recommendations on which of the temporary regulatory flexibilities instituted during the COVID-19 Public Health Emergency (PHE) should be extended beyond the PHE. The other asked for information on leveraging novel technologies to manage chronic diseases in aging populations living in underserved areas.